Pharma-Bio Serv (PBSV) Cash from Investing Activities Growth (5y) (2015 - 2026)
Powered by 
Analysis
Pharma-Bio Serv (PBSV) Cash from Investing Activities Growth (5y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Accenture | 124.62 Bn | 115.58 Bn | 6.13 Bn |
| 2 | UL Solutions | 14.92 Bn | 14.51 Bn | 417.00 Mn |
| 3 | Gartner | 11.76 Bn | 10.28 Bn | 1.19 Bn |
| 4 | Tetra Tech | 9.19 Bn | 8.96 Bn | 243.21 Mn |
| 5 | Booz Allen Hamilton Holding | 8.76 Bn | 8.22 Bn | 1.46 Bn |
| 6 | Genpact | 6.27 Bn | 5.75 Bn | 490.34 Mn |
| 7 | Korn Ferry | 4.28 Bn | 3.15 Bn | 685.99 Mn |
| 8 | Fti Consulting | 4.20 Bn | 4.04 Bn | 316.27 Mn |
| 9 | Grand Canyon Education | 4.01 Bn | 3.73 Bn | 204.08 Mn |
| 10 | Pharma-Bio Serv | 12.37 Mn | 3.89 Mn | 902,041.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | -104.75% |
| Jan 31, 2026 | 17.27% |
| Oct 31, 2025 | -166.93% |
| Jul 31, 2025 | 228.81% |
| Apr 30, 2025 | -190.68% |
| Jan 31, 2025 | 145.55% |
| Oct 31, 2024 | -32.68% |
| Jul 31, 2024 | 230.52% |
| Apr 30, 2024 | -23.00% |
| Jan 31, 2024 | -159.24% |
| Oct 31, 2023 | 163.82% |
| Apr 30, 2023 | 236.01% |
| Jan 31, 2023 | -176.12% |
| Oct 31, 2022 | -15.32% |
| Jul 31, 2022 | -18.02% |
| Apr 30, 2022 | 36.83% |
| Jan 31, 2022 | 69.98% |
| Oct 31, 2021 | 14.88% |
| Jul 31, 2021 | 56.65% |
| Apr 30, 2021 | 17.79% |